Our study comprehensively investigated the changes in the transcriptomics, proteomics, and metabolomics levels of GBM cells after OXA treatment, explored the consistency between omics, and screened some possible key pathways, including the FoxO signaling pathway, PI3K-AKT signaling pathway, and ferroptosis. Here, AKT1 is linked to glioblastoma.